Canine 1-Cv

Designed to enhance the immune response and offer protection against canine coronavirus.

CANINE CORONAVIRUS VACCINE

Nobivac® Canine 1-Cv is a killed virus vaccine recommended to protect against canine coronavirus.

  • The virus has been inactivated and combined with an adjuvant designed to enhance the immune response
  • Approved for the vaccination of healthy dogs as an aid in the prevention of disease caused by canine coronavirus infection

INDICATIONS:

Recommended for use in healthy dogs 6 weeks of age or older.

ADMINISTRATION AND DOSAGE

  • Inject initial 1 mL dose subcutaneously or intramuscularly
  • The initial dose may be given at 6 weeks of age
  • A second, required dose is given 2-4 weeks later
  • Annual revaccination with one dose is recommended
  • Use entire contents immediately
  • Available in a 25 x 1 mL dose presentation

ALSO AVAILABLE IN OTHER FORMULATIONS

Professional Resources and Educational Materials

Keep your clinic and staff informed and aware of diseases and outbreaks.

AAHA Canine Vaccination Guidelines

In-depth information about canine vaccinations and veterinary best practices.

Download

Nobivac® Social Media Kits

Digital Assets

Use these ready-to-share posts to educate pet parents and drive business to your clinic for preventative care.

Download

Quick Guide to Lepto

eBook

A handy guide to protect dogs and prevent the spread of leptospirosis.

Download

No items to show.

Loading…

References:

View All Nobivac References